Search

everythinglearnresearchcommunity

for

Search:↓

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

HMBi supplementation boosts cashmere growth by affecting specific metabolic and signaling pathways in goats.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

5-Bromo-3,4-dihydroxybenzaldehyde could potentially help hair growth by activating certain cell pathways and inhibiting others.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Taking biotin can lead to incorrect low results in free testosterone tests.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.

Sebaceous glands help study fatty acid transporters and binding proteins.

LEF1 interacts with Vitamin D Receptor, affecting hair follicle regeneration and this could be linked to hair loss conditions.

Isoliensinine, a natural compound, prevents stress-related hair greying by blocking a specific receptor on hair cells.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

The ABCA4 gene protects hair follicle stem cells from toxic vitamin A byproducts.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Birt–Hogg–Dubé Syndrome requires genetic testing for accurate diagnosis due to its similarities with tuberous sclerosis.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Cells lacking the Bax protein can outcompete others, leading to better tissue repair and hair growth.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

TGF-β and TNF influence hair follicle cell fate, with TNF being more effective in triggering cell death.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Tmem30b is essential for hearing by maintaining hair cell structure in the ear.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

Box A of HMGB1 can improve stem cell function, aiding anti-aging therapy.